IWC
RAPP

Integrated Wealth Concepts’s Rapport Therapeutics RAPP Stock Holding History

Integrated Wealth Concepts’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.17K Buy
+220
New +$8.09K ﹤0.01% 4615

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $498M AUM 267.53% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Integrated Wealth Concepts's RAPP Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Rapport Therapeutics (RAPP) in Q2 2026: 220 shares worth $9.17K. The stake represents ﹤0.01% of the portfolio and ranks #4615 among its holdings.

160 funds tracked by Wall St. Rank hold RAPP as of Q2 2026.

  • Integrated Wealth Concepts held 220 shares of Rapport Therapeutics worth $9.17K as of Q2 2026.
  • Rapport Therapeutics was a new Integrated Wealth Concepts position in Q2 2026.
  • Rapport Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #4615 holding.
  • 160 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.